Amygdala regulation of fear and emotionality in fragile X syndrome
- PMID: 21893939
- PMCID: PMC3254036
- DOI: 10.1159/000329424
Amygdala regulation of fear and emotionality in fragile X syndrome
Abstract
Fear is a universal response to a threat to one's body or social status. Disruption in the detection and response of the brain's fear system is commonly observed in a variety of neurodevelopmental disorders, including fragile X syndrome (FXS), a brain disorder characterized by variable cognitive impairment and behavioral disturbances such as social avoidance and anxiety. The amygdala is highly involved in mediating fear processing, and increasing evidence supports the idea that inhibitory circuits play a key role in regulating the flow of information associated with fear conditioning in the amygdala. Here, we review the known and potential importance of amygdala fear circuits in FXS, and how developmental studies are critical to understand the formation and function of neuronal circuits that modulate amygdala-based behaviors.
Copyright © 2011 S. Karger AG, Basel.
Figures



Similar articles
-
Homeostatic responses fail to correct defective amygdala inhibitory circuit maturation in fragile X syndrome.J Neurosci. 2013 Apr 24;33(17):7548-58. doi: 10.1523/JNEUROSCI.2764-12.2013. J Neurosci. 2013. PMID: 23616559 Free PMC article.
-
The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome.Dev Neurosci. 2011;33(5):395-403. doi: 10.1159/000332884. Epub 2011 Nov 8. Dev Neurosci. 2011. PMID: 22067669 Free PMC article.
-
The emotional brain, fear, and the amygdala.Cell Mol Neurobiol. 2003 Oct;23(4-5):727-38. doi: 10.1023/a:1025048802629. Cell Mol Neurobiol. 2003. PMID: 14514027 Free PMC article. Review.
-
Inhibitory networks of the amygdala for emotional memory.Front Neural Circuits. 2013 Aug 1;7:129. doi: 10.3389/fncir.2013.00129. eCollection 2013. Front Neural Circuits. 2013. PMID: 23914157 Free PMC article. Review.
-
Emotion potentiated startle in fragile X syndrome.J Autism Dev Disord. 2014 Oct;44(10):2536-46. doi: 10.1007/s10803-014-2125-7. J Autism Dev Disord. 2014. PMID: 24816942 Free PMC article. Clinical Trial.
Cited by
-
Neurodevelopment and early pharmacological interventions in Fragile X Syndrome.Front Neurosci. 2023 Aug 2;17:1213410. doi: 10.3389/fnins.2023.1213410. eCollection 2023. Front Neurosci. 2023. PMID: 37599992 Free PMC article. Review.
-
Homeostatic responses fail to correct defective amygdala inhibitory circuit maturation in fragile X syndrome.J Neurosci. 2013 Apr 24;33(17):7548-58. doi: 10.1523/JNEUROSCI.2764-12.2013. J Neurosci. 2013. PMID: 23616559 Free PMC article.
-
Elevated FMR1-mRNA and lowered FMRP - A double-hit mechanism for psychiatric features in men with FMR1 premutations.Transl Psychiatry. 2020 Jun 23;10(1):205. doi: 10.1038/s41398-020-00863-w. Transl Psychiatry. 2020. PMID: 32576818 Free PMC article.
-
Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective.Brain Sci. 2018 Dec 5;8(12):214. doi: 10.3390/brainsci8120214. Brain Sci. 2018. PMID: 30563047 Free PMC article. Review.
-
SLC4A10 mutation causes a neurological disorder associated with impaired GABAergic transmission.Brain. 2023 Nov 2;146(11):4547-4561. doi: 10.1093/brain/awad235. Brain. 2023. PMID: 37459438 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical